[vc_row][vc_column][vc_single_image image=”10322″ img_size=”full” alignment=”center”][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Dr. Peter Adamson, Chair of the Children’s Oncology Group (COG), shared information that COG has received along with a perspective on childhood cancer drug shortages, including the current situation with vincristine. We were pleased to join with the Alliance for Childhood Cancer to invite members of the two coalitions and the wider community this Community webinar. We offered this webinar so that the community could have a better understanding of the shortage, how to work with care providers, how to contact the FDA when problems arise from the shortage, and advocacy steps being taken.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_video link=”https://youtu.be/egfudrUGfYE” align=”center”][/vc_column][/vc_row]
